There are 2789 resources available
369P - Characterization of the inflammatory tumor microenvironment composition in brain metastases after failure of immune checkpoint inhibitor therapy
Presenter: Angelika M. Starzer
Session: ePoster Display
370P - Prospective study of apatinib combined with whole brain radiation therapy and simultaneous integrated boost for brain metastases from lung cancer
Presenter: Guang Han
Session: ePoster Display
371P - Low-dose bevacizumab for the treatment of focal post-radiation necrosis of the brain
Presenter: Jens Tijtgat
Session: ePoster Display
372P - The prognostic value of liver metastases and how affects the applicability of the lung-molGPA in non-small cell lung cancer patients with brain metastases
Presenter: Joel Rafael Veas Rodriguez
Session: ePoster Display
373P - Brain metastases: Extracranial disease status as a prognostic factor after whole brain radiotherapy. Results from a prospective, population-based study
Presenter: Olav Yri
Session: ePoster Display
427P - Real world data of trifluridine/tipiracil in refractory mCRC: A multicenter experience at four GEODA Spanish hospitals
Presenter: Julia Martinez Perez
Session: ePoster Display
375P - Clinical outcomes of targeting therapy with BRAF/MEK inhibitors in patients with BRAF V600-mutated brain tumors
Presenter: Marta Mejías Trueba
Session: ePoster Display
376P - Nucleolin and its prognostic value in pediatric patients with intracranial ependymoma: A systematic review and meta-analysis
Presenter: Jeremiah Wijaya
Session: ePoster Display
377P - Comparison of current guidelines and real-world evidence data for the treatment of glioblastoma across Europe
Presenter: Carrmen Escorial
Session: ePoster Display
430P - Learning from FOCUS4: A molecularly stratified adaptive trial platform in metastatic colorectal cancer
Presenter: Janet Graham
Session: ePoster Display
Resources:
Abstract